Blog
RSS FeedPosted by Michael Wonder on 12 Apr 2024
More treatments available to 30,000 New Zealanders
12 April 2024 - PHARMAC has decided to fund several medicines and widen access to two others, a move that will ...
Posted by Michael Wonder on 12 Apr 2024
Waiting for new medicines in Canada, Europe, and the United States: study finds Americans get better and faster access to innovative drugs
11 April 2024 - A recent study published by the Canadian Health Policy Institute examined the availability and wait times ...
Posted by Michael Wonder on 11 Apr 2024
'Really expensive': migraine expert calls for more funded treatments
10 April 2024 - Migraine experts are advocating for PHARMAC to fund a new generation of migraine drugs that target ...
Posted by Michael Wonder on 10 Apr 2024
New target zero initiative aims to help improve access to new drugs
9 April 2024 - Target Zero is a new initiative that aims to improve the time to access for patients ...
Posted by Michael Wonder on 10 Apr 2024
Calls for supplement to treat rare metabolic disorder to be relisted on PBS
10 April 2024 - An Adelaide mother says a vital supplement that assists her sons with a rare metabolic disorder ...
Posted by Michael Wonder on 10 Apr 2024
Mum’s plea: ‘I’m dying but $7.70 could save my kids’
10 April 2024 - Amelia Ramsay has battled all her life – and now she may have to watch her kids ...
Posted by Michael Wonder on 08 Apr 2024
Australians benefit from cheaper medicines on the PBS
8 April 2024 - Australians with high cholesterol, chronic kidney disease and ovarian cancer now have access to cheaper medicines under ...
Posted by Michael Wonder on 06 Apr 2024
Nurtec ODT is now available in Canada for the treatment of acute migraine
4 April 2024 - More than one billion people worldwide live with migraine, and the World Health Organization classifies migraine ...
Posted by Michael Wonder on 05 Apr 2024
Bausch Health Canada announces first public drug plan listings for Uceris (budesonide) aerosol foam to help address the unmet need for the treatment of mild to moderate distal ulcerative colitis in adults
3 April 2024 - Bausch Health Canada today announced the first public drug plan listings for Uceris (budesonide) aerosol foam ...
Posted by Michael Wonder on 02 Apr 2024
Cancer experts urge PHARMAC to fast-track 'life-saving' Keytruda
2 April 2024 - Breast cancer experts have urged PHARMAC to fast-track the drug Keytruda, for Kiwis with an aggressive ...
Posted by Michael Wonder on 31 Mar 2024
Schedule of Pharmaceutical Benefits - 1 April 2024
1 April 2024 - The April 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 Mar 2024
New Zealand Pharmaceutical Schedule - 1 April 2024
1 April 2024 - The April 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 27 Mar 2024
PHARMAC funds new treatments for breast and blood cancer
27 March 2024 - PHARMAC is funding two new cancer treatments, one for advanced breast cancer (ribociclib succinate) and one ...
Posted by Michael Wonder on 17 Mar 2024
Funding process for child cancer medicines to remain
15 March 2024 - Pharmac has decided to keep Rule 8.1b, which allows medicines for treating children with cancer to ...
Posted by Michael Wonder on 05 Mar 2024
Nine drug formularies in Canada list Evenity for reimbursement for the treatment of osteoporosis in post-menopausal women as high risk of fracture
5 March 2024 - Multiple formulary listings are a step forward to ensuring that post-menopausal women have access to medicines ...